Search Results

Article

February 2015

Dr. Kevin Flanigan discusses IRES-Induced Dystrophin as a potential therapy for DMD.

Project 2

Led by Kevin Flanigan, MD, Research Project 2 of our MDSRC Program has a long-term goal to develop vectors that maximize RNA splice alteration efficiency to provide the best potential outcome for individual patients.

Article

April 2012

Dr. Jerry Mendell discusses newborn screening in duchenne muscular dystrophy.

Article

Gene Therapy Fellowship Application and Selection

Interested in applying for our Neuromuscular Genetic Therapeutics Fellowship? Learn more about our Neuromuscular Genetic Therapeutics Fellowship application and selection.

Article

September 2012

Professor Francesco Muntoni discusses congenital muscular dystrophies.

News

Flanigan Named to Neuromuscular, Gene Therapy Leadership Roles

Beginning January 1, 2017, Kevin Flanigan, MD, will become the director of the Center for Gene Therapy and the Neuromuscular Disorders program at Nationwide Children’s Hospital. Dr.

Article

January 2013

Dr. James Ervasti discusses stability of therapeutic forms of dystrophin.

News

Cure Duchenne to Host a Webinar on Duplication Research for Duchenne Muscular Dystrophy with Dr. Kevin Flanigan from Nationwide Childrens Hospital on April 6

NEWPORT BEACH, Calif. -- CureDuchenne, a nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy, will host an “Update on Duplication Mutation Research for Duchenne Muscular Dystrophy” webinar with Dr.

Article

July 2013

Dr. Jeff Chamberlain discusses gene and cell mediated therapies for muscular dystrophy.